ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026
Researchers reported a 37% drop in the intact HIV reservoir after five doses of N-803, with four participants still off antiretroviral therapy.
9 Articles
9 Articles
The Toronto Star
ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026
CHAPEL HILL, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced today that it will make three presentations
This week two new cases of HIV infection remission after stem cell transplantation were announced during the 26th International AIDS Conference in Rio de Janeiro. Thus, 13 HIV infected patients who did not have virus detected in the blood after the type of treatment. One of the cases is that of a man called "Kansas City patient" (United States), who, at age 21, discovered that, in addition to being infected with HIV, he suffered from acute myelo…
Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026
Superiority data from LATA, together with OPERA findings, add to the clinical and real-world evidence base for long-acting injectable Cabenuva Six-month follow-up CLARITY data further reinforce a more favourable injection experience with long-acting cabotegravir compared with lenacapavir after a single dose; additional studies showcase high real-world adherence and a preference for Apretude among previous oral more... The post Cabenuva demonstra…
The advancement of anti-HIV drugs is transforming the profile of the epidemic in the world. A commission published by the scientific journal The Lancet HIV projects that, by 2040, more than half of the people living with the virus will be 50 years old or older.For experts, the change will require a reorganization of health systems, which will need to deal more and more with diseases related to aging.Number of elderly people living with HIV shoul…
Report published in The Lancet HIV magazine projects that more than 20 million people living with the virus will be in this age group and advocates changes in patient care
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
